Dr. Reddy’s Laboratories announced today that it has entered into an agreement with JB Chemicals & Pharmaceuticals to acquire their pharmaceutical prescription portfolio in the Russia and other CIS regions. The agreement involves acquisition of 20 brands, key ones being Metrogyl and Jocet, for a consideration of USD 34.85 million.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”